Chiropractors in Marana, AZ Accepting Medicare

4 Chiropractors found. Showing 1 - 4

Dr. Julia Hennagir, D.C. Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 9775 N Clayton Rd, Marana, AZ 85653 Phone: 520-906-6902

Marana Chiropractic Pllc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 13808 N Sandario Rd Ste 110, Marana, AZ 85653 Phone: 520-261-9153

Dr. Brian James Schnurr Jr., D.C. Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 4688 W Tangerine Rd, Unit 9203, Marana, AZ 85658 Phone: 248-930-1599

Dove Mountain Chiropractic And Massage Llc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 12040 N Thornydale Rd, Ste 102, Marana, AZ 85658 Phone: 248-930-1599

News Archive

Viamet commences VT-1161 Phase 1 clinical study to treat fungal infections

Viamet Pharmaceuticals, Inc., announced today that dosing has begun in a Phase 1 clinical study of VT-1161, an oral, potent and selective antifungal agent. VT-1161 is a novel small molecule discovered by Viamet Pharmaceuticals using its proprietary Metallophile Technology.

Viewpoints: The importance of hepatitis C testing; Medicaid needs to provide coverage for circumcision

I consider myself to be a fortunate person. I have a good education, a great job and excellent health insurance. I am a baby boomer who has aged reasonably well and can look forward to a fairly comfortable retirement. I am also fortunate because I was diagnosed with hepatitis C by a proactive and knowledgeable doctor in the late 1990s and had the opportunity to be treated and cured. The odds are that if I had not been diagnosed and treated, I would be on a liver transplant list right now, have liver cancer or even be dead from this disease.

Study investigates long-COVID symptoms in people recovering from COVID-19 infection

This new study from the University of Oxford and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre (BRC) investigated long-COVID in over 270,000 people recovering from COVID-19 infection, using data from the US-based TriNetX electronic health record network.

Simple blood test can predict evidence of TBI on radiographic imaging, injury severity

New study results show that a simple blood test to measure brain-specific proteins released after a person suffers a traumatic brain injury (TBI) can reliably predict both evidence of TBI on radiographic imaging and injury severity.

Soligenix initiates SGX942 Phase 2 study for treatment of oral mucositis

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that it has initiated a Phase 2, randomized, double-blind, placebo-controlled study evaluating SGX942, a first-in-class innate defense regulator, as a treatment for oral mucositis in patients undergoing chemoradiation therapy for head and neck cancer.

Read more Medical News

› Verified 6 days ago